Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Warming impacts on boreal fen CO2 exchange under wet and dry conditions.

Laine AM, Mäkiranta P, Laiho R, Mehtätalo L, Penttilä T, Korrensalo A, Minkkinen K, Fritze H, Tuittila ES.

Glob Chang Biol. 2019 Jun;25(6):1995-2008. doi: 10.1111/gcb.14617. Epub 2019 Apr 2.

PMID:
30854735
2.

Differences in the risk of stroke, bleeding events, and mortality between female and male patients with atrial fibrillation during warfarin therapy.

Penttilä T, Lehto M, Niiranen J, Mehtälä J, Khanfir H, Lassila R, Raatikainen P.

Eur Heart J Cardiovasc Pharmacother. 2019 Jan 1;5(1):29-36. doi: 10.1093/ehjcvp/pvy026.

PMID:
30052822
3.

The influence of oxygen and methane on nitrogen fixation in subarctic Sphagnum mosses.

Kox MAR, Aalto SL, Penttilä T, Ettwig KF, Jetten MSM, van Kessel MAHJ.

AMB Express. 2018 May 5;8(1):76. doi: 10.1186/s13568-018-0607-2.

4.

The quality of warfarin therapy and CHA2DS2-VASc score associate with the incidence of myocardial infarction and cardiovascular outcome in patients with atrial fibrillation: data from the nationwide FinWAF Registry.

Raatikainen MJP, Penttilä T, Korhonen P, Mehtälä J, Lassila R, Lehto M.

Eur Heart J Cardiovasc Pharmacother. 2018 Oct 1;4(4):211-219. doi: 10.1093/ehjcvp/pvy009.

PMID:
29514184
5.

Responses of phenology and biomass production of boreal fens to climate warming under different water-table level regimes.

Mäkiranta P, Laiho R, Mehtätalo L, Straková P, Sormunen J, Minkkinen K, Penttilä T, Fritze H, Tuittila ES.

Glob Chang Biol. 2018 Mar;24(3):944-956. doi: 10.1111/gcb.13934. Epub 2017 Nov 13.

PMID:
28994163
6.

Antiarrhythmic drug therapy among patients presenting to emergency department with symptomatic atrial fibrillation - a prospective nationwide cohort.

Penttilä T, Mäkynen H, Hartikainen J, Hyppölä H, Lauri T, Lehto M, Lund J, Raatikainen MJP; FinFib2 investigators.

Scand J Trauma Resusc Emerg Med. 2017 Aug 15;25(1):81. doi: 10.1186/s13049-017-0424-7.

7.

Natalizumab treatment leads to an increase in circulating CXCR3-expressing B cells.

Saraste M, Penttilä TL, Airas L.

Neurol Neuroimmunol Neuroinflamm. 2016 Oct 24;3(6):e292. eCollection 2016 Dec.

8.

Anticoagulation therapy among patients presenting to the emergency department with symptomatic atrial fibrillation - the FinFib2 study.

Penttilä T, Mäkynen H, Hartikainen J, Lauri T, Lehto M, Lund J, Mäkijärvi M, Raatikainen P.

Eur J Emerg Med. 2017 Oct;24(5):347-352. doi: 10.1097/MEJ.0000000000000402.

PMID:
27097066
9.

Microbial ecology in a future climate: effects of temperature and moisture on microbial communities of two boreal fens.

Peltoniemi K, Laiho R, Juottonen H, Kiikkilä O, Mäkiranta P, Minkkinen K, Pennanen T, Penttilä T, Sarjala T, Tuittila ES, Tuomivirta T, Fritze H.

FEMS Microbiol Ecol. 2015 Jul;91(7). pii: fiv062. doi: 10.1093/femsec/fiv062. Epub 2015 Jun 10.

PMID:
26066028
10.

Comparative analysis of minimal residual disease detection by multiparameter flow cytometry and enhanced ASO RQ-PCR in multiple myeloma.

Silvennoinen R, Lundan T, Kairisto V, Pelliniemi TT, Putkonen M, Anttila P, Huotari V, Mäntymaa P, Siitonen S, Uotila L, Penttilä TL, Juvonen V, Selander T, Remes K.

Blood Cancer J. 2014 Oct 10;4:e250. doi: 10.1038/bcj.2014.69.

11.

Host cell Golgi anti-apoptotic protein (GAAP) and growth of Chlamydia pneumoniae.

Markkula E, Hulkkonen J, Penttilä T, Puolakkainen M.

Microb Pathog. 2013 Jan;54:46-53. doi: 10.1016/j.micpath.2012.09.004. Epub 2012 Sep 21.

PMID:
23000903
12.

Flotillin-1 (Reggie-2) contributes to Chlamydia pneumoniae growth and is associated with bacterial inclusion.

Korhonen JT, Puolakkainen M, Häivälä R, Penttilä T, Haveri A, Markkula E, Lahesmaa R.

Infect Immun. 2012 Mar;80(3):1072-8. doi: 10.1128/IAI.05528-11. Epub 2012 Jan 3.

13.

Quality control of flow cytometry data analysis for evaluation of minimal residual disease in bone marrow from acute leukemia patients during treatment.

Björklund E, Matinlauri I, Tierens A, Axelsson S, Forestier E, Jacobsson S, Ahlberg AJ, Kauric G, Mäntymaa P, Osnes L, Penttilä TL, Marquart H, Savolainen ER, Siitonen S, Torikka K, Mazur J, Porwit A.

J Pediatr Hematol Oncol. 2009 Jun;31(6):406-15. doi: 10.1097/MPH.0b013e3181a1c0e8.

PMID:
19648789
14.

Chlamydia pneumoniae infection in IL-10 knock out mice: accelerated clearance but severe pulmonary inflammatory response.

Penttilä T, Haveri A, Tammiruusu A, Vuola JM, Lahesmaa R, Puolakkainen M.

Microb Pathog. 2008 Jul;45(1):25-9. doi: 10.1016/j.micpath.2008.02.004. Epub 2008 Apr 1.

PMID:
18456450
15.

Stem cell transplantation in poor-risk chronic lymphocytic leukemia: assessment of post-transplant minimal residual disease using four- and six-color flow cytometry and allele-specific RQ-PCR.

Itälä M, Huhtinen AR, Juvonen V, Kairisto V, Pelliniemi TT, Penttilä TL, Rauhala A, Tienhaara A, Remes K.

Eur J Haematol. 2008 Aug;81(2):100-6. doi: 10.1111/j.1600-0609.2008.01082.x. Epub 2008 Apr 10.

PMID:
18410542
16.

Responses of aerobic microbial communities and soil respiration to water-level drawdown in a northern boreal fen.

Jaatinen K, Laiho R, Vuorenmaa A, del Castillo U, Minkkinen K, Pennanen T, Penttilä T, Fritze H.

Environ Microbiol. 2008 Feb;10(2):339-53. Epub 2007 Sep 30.

PMID:
17903215
17.

Intranasal administration of chlamydial outer protein N (CopN) induces protection against pulmonary Chlamydia pneumoniae infection in a mouse model.

Tammiruusu A, Penttilä T, Lahesmaa R, Sarvas M, Puolakkainen M, Vuola JM.

Vaccine. 2007 Jan 4;25(2):283-90. Epub 2006 Aug 11.

PMID:
16949182
18.

Systemic and mucosal antibody response in experimental Chlamydia pneumoniae infection of mice.

Penttilä T, Wahlström E, Vuola JM, Sarvas M, Puolakkainen M.

Comp Med. 2006 Aug;56(4):272-8.

PMID:
16941954
19.

DNA immunization followed by a viral vector booster in a Chlamydia pneumoniae mouse model.

Penttilä T, Tammiruusu A, Liljeström P, Sarvas M, Mäkelä PH, Vuola JM, Puolakkainen M.

Vaccine. 2004 Sep 3;22(25-26):3386-94.

PMID:
15308363
20.
21.

Microtubule-associated epithelial protein E-MAP-115 is localized in the spermatid manchette.

Penttilä TL, Parvinen M, Paranko J.

Int J Androl. 2003 Jun;26(3):166-74.

PMID:
12755995
22.

Production of Chlamydia pneumoniae proteins in Bacillus subtilis and their use in characterizing immune responses in the experimental infection model.

Airaksinen U, Penttilä T, Wahlström E, Vuola JM, Puolakkainen M, Sarvas M.

Clin Diagn Lab Immunol. 2003 May;10(3):367-75. Erratum in: Clin Diagn Lab Immunol. 2004 Mar;11(2):436.

23.

Failed regrowth of the harvested semitendinosus tendon: a rare complication of tendon harvest after anterior cruciate ligament reconstruction.

Järvinen TL, Järvinen TA, Penttilä T, Harilainen A, Sandelin J, Paakkala T.

Arthroscopy. 2003 Apr;19(4):E31.

PMID:
12671606
24.

No evidence of acute Chlamydia pneumoniae infection in patients with Bell's palsy.

Pitkäranta A, Vaheri A, Penttilä T, Puolakkainen M.

Otolaryngol Head Neck Surg. 2002 Apr;126(4):415-6.

PMID:
11997783
25.

Cell- and stage-specific high-level expression of TBP-related factor 2 (TRF2) during mouse spermatogenesis.

Zhang D, Penttila TL, Morris PL, Roeder RG.

Mech Dev. 2001 Aug;106(1-2):203-5.

26.

Spermiogenesis deficiency in mice lacking the Trf2 gene.

Zhang D, Penttila TL, Morris PL, Teichmann M, Roeder RG.

Science. 2001 May 11;292(5519):1153-5.

PMID:
11352070
27.

Immunity to Chlamydia pneumoniae induced by vaccination with DNA vectors expressing a cytoplasmic protein (Hsp60) or outer membrane proteins (MOMP and Omp2).

Penttilä T, Vuola JM, Puurula V, Anttila M, Sarvas M, Rautonen N, Mäkelä PH, Puolakkainen M.

Vaccine. 2000 Dec 8;19(9-10):1256-65.

PMID:
11137265
28.
29.

Obesity regulates bioavailable testosterone levels in women with or without polycystic ovary syndrome.

Penttilä TL, Koskinen P, Penttilä TA, Anttila L, Irjala K.

Fertil Steril. 1999 Mar;71(3):457-61.

PMID:
10065782
30.

Serum total renin levels after ovarian electrocautery in women with polycystic ovary syndrome.

Anttila L, Penttilä TA, Matinlauri I, Koskinen P, Irjala K.

Gynecol Endocrinol. 1998 Oct;12(5):327-31.

PMID:
9859025
31.

Serum leptin concentrations in women with polycystic ovary syndrome.

Rouru J, Anttila L, Koskinen P, Penttilä TA, Irjala K, Huupponen R, Koulu M.

J Clin Endocrinol Metab. 1997 Jun;82(6):1697-700.

PMID:
9177366
32.

Visualization of clinical data with neural networks, case study: polycystic ovary syndrome.

Lehtinen JC, Forsström J, Koskinen P, Penttilä TA, Järvi T, Anttila L.

Int J Med Inform. 1997 Apr;44(2):145-55.

PMID:
9291006
33.

FGF-8 is expressed during specific phases of rodent oocyte and spermatogonium development.

Valve E, Penttilä TL, Paranko J, Härkönen P.

Biochem Biophys Res Commun. 1997 Mar 6;232(1):173-7.

PMID:
9125125
34.

Normal serum uric acid concentrations in women with polycystic ovary syndrome.

Anttila L, Rouru J, Penttilä T, Irjala K.

Hum Reprod. 1996 Nov;11(11):2405-7.

PMID:
8981120
35.

Stage-specific expression of the FSH receptor gene in the prepubertal and adult rat seminiferous epithelium.

Rannikko A, Penttilä TL, Zhang FP, Toppari J, Parvinen M, Huhtaniemi I.

J Endocrinol. 1996 Oct;151(1):29-35.

PMID:
8943766
36.

Optimal use of hormone determinations in the biochemical diagnosis of the polycystic ovary syndrome.

Koskinen P, Penttilä TA, Anttila L, Erkkola R, Irjala K.

Fertil Steril. 1996 Mar;65(3):517-22.

PMID:
8774279
37.

Serum free testosterone in polycystic ovary syndrome measured with a new reference method.

Penttilä TA, Anttila L, Törmä A, Koskinen P, Erkkola R, Irjala K.

Fertil Steril. 1996 Jan;65(1):55-60.

PMID:
8557155
38.

Follicle-stimulating hormone regulates the expression of cyclic protein-2/cathepsin L messenger ribonucleic acid in rat Sertoli cells in a stage-specific manner.

Penttilä TL, Hakovirta H, Mali P, Wright WW, Parvinen M.

Mol Cell Endocrinol. 1995 Sep 22;113(2):175-81.

PMID:
8674825
39.

Haploid gene expression: temporal onset and storage patterns of 13 novel transcripts during rat and mouse spermiogenesis.

Penttilä TL, Yuan L, Mali P, Höög C, Parvinen M.

Biol Reprod. 1995 Sep;53(3):499-510.

PMID:
7578672
40.

Expression of immediate early genes in tubular cells of rat testis.

Schultz R, Penttilä TL, Parvinen M, Persson H, Hökfelt T, Pelto-Huikko M.

Biol Reprod. 1995 Jun;52(6):1215-26.

PMID:
7632829
41.

Expression of the mad gene during cell differentiation in vivo and its inhibition of cell growth in vitro.

Västrik I, Kaipainen A, Penttilä TL, Lymboussakis A, Alitalo R, Parvinen M, Alitalo K.

J Cell Biol. 1995 Mar;128(6):1197-208.

42.
43.

Stage-specific expression of pituitary adenylate cyclase-activating polypeptide (PACAP) mRNA in the rat seminiferous tubules.

Kononen J, Paavola M, Penttilä TL, Parvinen M, Pelto-Huikko M.

Endocrinology. 1994 Nov;135(5):2291-4.

PMID:
7956953
44.

Expression of inhibin alpha, beta A and beta B messenger ribonucleic acids in the normal human ovary and in polycystic ovarian syndrome.

Jaatinen TA, Penttilä TL, Kaipia A, Ekfors T, Parvinen M, Toppari J.

J Endocrinol. 1994 Oct;143(1):127-37.

PMID:
7964311
45.

Localization of urokinase- and tissue-type plasminogen activator mRNAs in rat testes.

Penttilä TL, Kaipia A, Toppari J, Parvinen M, Mali P.

Mol Cell Endocrinol. 1994 Oct;105(1):55-64.

PMID:
7821718
46.

Follicle-stimulating hormone regulation of inhibin alpha-subunit mRNA in staged rat seminiferous tubules.

Kaipia A, Penttilä TL, Toppari J.

Eur J Endocrinol. 1994 Sep;131(3):323-9.

PMID:
7921219
47.

Inhibition of the mitochondrial calcium uniporter by antibodies against a 40-kDa glycoproteinT.

Saris NE, Sirota TV, Virtanen I, Niva K, Penttilä T, Dolgachova LP, Mironova GD.

J Bioenerg Biomembr. 1993 Jun;25(3):307-12.

PMID:
7688718
48.

Interleukin-1 bioactivity and DNA synthesis in X-irradiated rat testes.

Hakovirta H, Penttilä TL, Pöllänen P, Fröysa B, Söder O, Parvinen M.

Int J Androl. 1993 Apr;16(2):159-64.

PMID:
8514429
49.

Expression of inhibin beta A and beta B, follistatin and activin-A receptor messenger ribonucleic acids in the rat seminiferous epithelium.

Kaipia A, Penttilä TL, Shimasaki S, Ling N, Parvinen M, Toppari J.

Endocrinology. 1992 Dec;131(6):2703-10.

PMID:
1332846
50.

FSH receptor mRNA is expressed stage-dependently during rat spermatogenesis.

Kliesch S, Penttilä TL, Gromoll J, Saunders PT, Nieschlag E, Parvinen M.

Mol Cell Endocrinol. 1992 Apr;84(3):R45-9.

PMID:
1587387

Supplemental Content

Loading ...
Support Center